For a better experience, Read this story in our App
-53.49
+ 1.05
+ 19.00
-261.00
-321.00
-53.49
+ 1.05
+ 1.05
+ 19.00
+ 19.00
-261.00
The United States Food and Drug Administration (US FDA) conducted a pre-approval inspection at Eugia Steriles, a 100 per cent subsidiary of Eugia Pharma Specialities and a step-down subsidiary of Aurobindo Pharma situated at Parawada Mandal, Anakapalli District, Andhra Pradesh, with five observations.
The inspection was conducted from February 10, 2025, to February 18, 2025. “The inspection concluded with 5 observations. The observations are procedural in nature and will be responded to within the stipulated time,’‘ Aurobindo Pharma said on Tuesday.
Published on February 19, 2025
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.